Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema.
Leukotriene (LT) generation has been implicated in the pathogenesis of the acute respiratory distress syndrome, ARDS. In the present study, we analysed broncho-alveolar lavage fluids of patients on mechanical ventilation because of ARDS (17 samples taken from 9 patients) or because of cardiogenic edema (8 samples taken from 6 patients) and of healthy volunteers (10 samples from different donors). LTs were separated as methylated and non-methylated compounds using different HPLC procedures, and were identified by chromatographic mobility, on-line UV-spectrum analysis and post HPLC immunoreactivity. In the lavage samples of the healthy volunteers and the patients with cardiogenic edema, no LTs were detected by these techniques (detection limit congruent to 0.1-0.2 ng/ml lavage fluid). By contrast, in 15 out of 17 samples from patients with ARDS LTB4 or its metabolites 20-OH-LTB4 and 20-COOH-LTB4 were detected. The endproduct of omega-oxidation, 20-COOH-LTB4, represented the quantitatively predominant compound, detected in the range of 0.3-2.6 ng/ml perfusate. We conclude that the chemotactic agent LTB4 may be involved in the amplification of inflammatory events encountered in ARDS, and that the oxidized metabolites of LTB4 are particularly suitable for monitoring lung leukotriene generation under conditions of neutrophil efflux and oxidative stress.
Seeger
W
W
Intensive Care Unit, Department of Internal Medicine, Giessen, FRG.
Grimminger
F
F
Barden
M
M
Becker
G
G
Lohmeyer
J
J
Heinrich
D
D
Lasch
H G
HG
D000328:Adult; D000368:Aged; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry*; D005260:Female; D006331:Heart Diseases / Q000150:complications*; D006801:Humans; D007975:Leukotriene B4 / Q000032:analysis* / Q000096:biosynthesis / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000737:chemistry; D010084:Oxidation-Reduction; D010743:Phospholipids / Q000032:analysis; D011506:Proteins / Q000032:analysis; D011654:Pulmonary Edema / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy; D013057:Spectrum Analysis
D010743:Phospholipids; D011506:Proteins; D007975:Leukotriene B4